What looms HUGE on the near term horizen is the Q1 and this is due to be released (tentatively) next week. There should be some very interesting data in this report...
1) Cash on hand (we had $14/M coming off fiscal 2000). This should give us an "idea" regarding the $20/M payment due 2/28.
2) A glimpse at how the company's doing with their digital businesses and if these revenues are continuing to narrow the gap against COM losses.
3) If there are any more details relating to the docHarbor sale. My guess is that there won't be.
4) Any numbers relating to businesses that have been sold. All of this money is mandated toward lowering their credit debt.
5) We also have another $17/M bond interest payment due 3/31 which simply must be taken care of, or else.
Most importantly, the Q1 should give us a feel for the continued progress ANCO is making in "leaning" itself down. Put differently, the Q1 should be the first document that shows the turn has been made.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM